Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment VA Serhiyenko, AA Serhiyenko Atlas of Science, 1-2, 2019 | 258 | 2019 |
Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment Serhiyenko, VA, Serhiyenko, AA World J Diabetes. 9 (1), 1-24, 2018 | 258 | 2018 |
Design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, C Nowack, P Kolkhof, ... American Journal of Nephrology 50 (5), 333-344, 2019 | 159 | 2019 |
Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis L Lauf, Z Ozsvár, I Mitha, J Regöly-Mérei, JM Embil, A Cooper, MB Sabol, ... Diagnostic microbiology and infectious disease 78 (4), 469-480, 2014 | 88 | 2014 |
Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives? VA Serhiyenko, AA Serhiyenko World journal of diabetes 6 (2), 245, 2015 | 55 | 2015 |
40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5–9 September 2004 M Veitenhansl, K Stegner, FX Hierl, C Dieterle, H Feldmeier, B Gutt, ... Diabetologia 47, A1-A464, 2004 | 52 | 2004 |
The correlations of glycated hemoglobin and carbohydrate metabolism parameters with heart rate variability in apparently healthy sedentary young male subjects A Cherkas, O Abrahamovych, S Golota, A Nersesyan, C Pichler, ... Redox biology 5, 301-307, 2015 | 43 | 2015 |
The role of biofactors in diabetic microvascular complications D Ziegler, M Porta, N Papanas, M Mota, G Jermendy, E Beltramo, ... Current Diabetes Reviews 18 (4), 2022 | 39 | 2022 |
Helicobacter pylori in sedentarymen is linked to higher heart rate, sympathetic activity, and insulin resistance but not inflammation or oxidative stress A Cherkas, P Eckl, F Guéraud, O Abrahamovych, V Serhiyenko, ... Croatian Medical Journal 57 (2), 141-149, 2016 | 33 | 2016 |
The Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues J Rodriguez-Saldana | 28* | 2019 |
Omega-3 polyunsaturated fatty acids in the treatment of diabetic cardiovascular autonomic neuropathy: A review VA Serhiyenko, LM Serhiyenko, AA Serhiyenko Omega-3: Dietary sources, biochemistry and impact on human health, 79-154, 2017 | 22 | 2017 |
Diabetic cardiac autonomic neuropathy V Serhiyenko, A Serhiyenko The Diabetes Textbook: Clinical Principles, Patient Management and Public …, 2023 | 19 | 2023 |
Alpha-lipoic acid: mechanisms of action and beneficial effects in the prevention and treatment of diabetic complications V Serhiyenko, L Serhiyenko, G Suslik, A Serhiyenko MOJ Public Health 7 (4), 174-178, 2018 | 19 | 2018 |
Рання діагностика функціонально-структурних порушень серцево-судинної системи у хворих на цукровий діабет 2 типу (огляд літератури та власних досліджень) ВО Сергієнко, ОО Сергієнко, АС Єфімов Журн. АМН України 16 (4), 630-650, 2010 | 18 | 2010 |
Патогенез діабетичної кардіоміопатії ВО Сергієнко, ОО Сергієнко, АС Єфімов Журн. АМН України 16 (2), 225-244, 2010 | 18 | 2010 |
Діабетична кардіоміопатія ВО Сергієнко, ОО Сергієнко Медична газета “Здоров’я України 21 сторіччя”, 17-18, 2020 | 14* | 2020 |
Дисліпопротеїнемії при цукровому діабеті 2 типу: основні напрямки лікування (огляд літератури та власних досліджень) ВО Сергієнко Журн. НАМН України 18 (2), 205-216, 2012 | 14 | 2012 |
Benfotiamine and type 2 diabetes mellitus V Serhiyenko, M Hotsko, O Snitynska, A Serhiyenko MOJ Public Health 7 (1), 00200 DOI: 10.15406/mojph.2018.07.0 29-3, 2018 | 12 | 2018 |
Simvastatin and omega-polyunsaturated fatty acids in the treatment of cardiomyopathy in type 2 diabetes mellitus patients VA Serhiyenko, AA Serhiyenko, VB Segin, LM Serhiyenko 77th EAS Congress. Istambul, 2008, 749, 2008 | 12 | 2008 |
Simvastatin and omega-polyunsaturated fatty acids in the treatment of cardiomyopathy in type 2 diabetes mellitus patients VA Serhiyenko, AA Serhiyenko, VB Segin, LM Serhiyenko 77th EAS Congress. Istambul, 2008, 749, 2008 | 12 | 2008 |